loadpatents
name:-0.029514074325562
name:-0.01361083984375
name:-0.015482187271118
MIYAKAWA; Tomoya Patent Filings

MIYAKAWA; Tomoya

Patent Applications and Registrations

Patent applications and USPTO patent grants for MIYAKAWA; Tomoya.The latest application filed is for "hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell".

Company Profile
13.13.27
  • MIYAKAWA; Tomoya - Tokyo JP
  • Miyakawa; Tomoya - Minato-ku JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Hsp70-derived Peptide, Pharmaceutical Composition For Treating Or Preventing Cancer Using Same, Immunity Inducer, And Method For Producing Antigen Presenting Cell
App 20220193213 - MIYAKAWA; Tomoya ;   et al.
2022-06-23
MEDICINE FOR TREATING CANCER BY ADMINISTERING A TOLL-LIKE RECEPTOR AGONIST AND LAG-3 IgG FUSION PROTEIN
App 20220175915 - MIYAKAWA; Tomoya ;   et al.
2022-06-09
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
Grant 11,304,997 - Miyakawa , et al. April 19, 2
2022-04-19
Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
Grant 11,291,718 - Miyakawa , et al. April 5, 2
2022-04-05
Medicine
App 20210000916 - MIYAKAWA; Tomoya ;   et al.
2021-01-07
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,875,900 - Miyakawa , et al. December 29, 2
2020-12-29
Method for treating cancer by adminstering poly I:C and LAG-3-IgG fusion protein
Grant 10,842,848 - Miyakawa , et al. November 24, 2
2020-11-24
Muc1-derived Peptide, And Pharmaceutical Composition For Treatment Or Prevention Of Cancer, Immunity-inducing Agent And Method F
App 20200181195 - MIYAKAWA; TOMOYA ;   et al.
2020-06-11
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using Same, Immunity Inducer, And Me
App 20200157163 - Miyakawa; Tomoya ;   et al.
2020-05-21
Hsp70-derived Peptide, Pharmaceutical Composition For Treating Or Preventing Cancer Using Same, Immunity Inducer, And Method For
App 20200121772 - Miyakawa; Tomoya ;   et al.
2020-04-23
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,590,179 - Miyakawa , et al.
2020-03-17
Medicine
App 20200038508 - MIYAKAWA; Tomoya ;   et al.
2020-02-06
HSP70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen presenting cell
Grant 10,537,626 - Miyakawa , et al. Ja
2020-01-21
Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using the same, immunity inducer, and method for producing antigen-presenting cells
Grant 10,526,388 - Miyakawa , et al. J
2020-01-07
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using Same, Immunity Inducer, And Method For Producing Antigen-presenting Cells
App 20190062389 - Miyakawa; Tomoya ;   et al.
2019-02-28
HSP70-Derived Peptide, Pharmaceutical Composition for Treating or Preventing Cancer Using Same, Immunity Inducer, and Method for Producing Antigen Presenting Cell
App 20180169199 - Miyakawa; Tomoya ;   et al.
2018-06-21
Peptide Derived From Gpc3, Pharmaceutical Composition For Treatment Or Prevention Of Cancer Using The Same, Immunity Inducer, And Method For Producing Antigen-presenting Cells
App 20180105567 - MIYAKAWA; Tomoya ;   et al.
2018-04-19
Medicine
App 20180071362 - MIYAKAWA; Tomoya ;   et al.
2018-03-15
Muc1-derived Peptide, And Pharmaceutical Composition For Treatment Or Prevention Of Cancer, Immunity-inducing Agent And Method For Manufacturing Antigen Presenting Cell Using Same
App 20180057531 - MIYAKAWA; Tomoya ;   et al.
2018-03-01
HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
Grant 9,353,151 - Miyakawa , et al. May 31, 2
2016-05-31
HLA-binding peptide, precursor thereof, and DNA fragment and recombinant vector coding for said HLA-binding peptide
Grant 9,045,531 - Miyakawa , et al. June 2, 2
2015-06-02
Hla-binding Peptides, Precursors Thereof, Dna Fragments And Recombinant Vectors That Code For Those Peptide Sequences
App 20150087809 - MIYAKAWA; Tomoya ;   et al.
2015-03-26
Hla-binding Peptide, And Dna Fragment And Recombinant Vector Coding For Said Hla-binding Peptide
App 20140094586 - MIYAKAWA; Tomoya ;   et al.
2014-04-03
HLA-binding peptide, and DNA fragment and recombinant vector coding for said HLA-binding peptide
Grant 8,487,076 - Miyakawa , et al. July 16, 2
2013-07-16
HLA-binding peptide, precursor thereof, DNA fragment and recombinant vector encoding the same
Grant 8,324,345 - Miyakawa , et al. December 4, 2
2012-12-04
Method For Inducing Cytotoxic T-cells, Cytotoxic T-cell Inducer, And Pharmaceutical Composition And Vaccine Employing Same
App 20110206711 - Miyakawa; Tomoya ;   et al.
2011-08-25
Hla-binding Peptide, Precursor Thereof, And Dna Fragment And Recombinant Vector Coding For Said Hla-binding Peptide
App 20110087005 - MIYAKAWA; Tomoya ;   et al.
2011-04-14
Hla-binding Peptides, Precursors Thereof, Dna Fragments And Recombinant Vectors That Code For Those Peptide Sequences
App 20110060124 - MIYAKAWA; Tomoya ;   et al.
2011-03-10
Method For Inducing Cytotoxic T-cells, Cytotoxic T-cell Inducers, And Pharmaceutical Compositions And Vaccines Employing Them
App 20100255020 - Miyakawa; Tomoya ;   et al.
2010-10-07
Hla-binding Peptide, Precursor Thereof, Dna Fragment And Recombinant Vector Encoding The Same
App 20100144025 - Miyakawa; Tomoya ;   et al.
2010-06-10
Sequence Prediction System
App 20090144209 - Miyakawa; Tomoya
2009-06-04
Hla-binding Peptide, Precursor Thereof, And Dna Fragment And Recombinant Vector Coding For Said Hla-binding Peptide
App 20090023895 - Miyakawa; Tomoya ;   et al.
2009-01-22
Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
App 20080306243 - Miyakawa; Tomoya ;   et al.
2008-12-11
Hla-Binding Peptide, and Dna Fragment and Recombinant Vector Coding for Said Hla-Binding Peptide
App 20080293916 - Miyakawa; Tomoya ;   et al.
2008-11-27
Hla-Binding Peptides, Precursors Thereof, Dna Fragments and Recombinant Vectors that Code for Those Peptide Sequences
App 20080249283 - Miyakawa; Tomoya ;   et al.
2008-10-09
System and method for searching information
App 20040205061 - Nakazato, Takeru ;   et al.
2004-10-14
Sequence display method and homology search method for facilitating access to information relating to regions of mutation and regions of similarity between plurality of sequences
App 20040117348 - Miyakawa, Tomoya ;   et al.
2004-06-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed